Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 92.24
-0.46 (-0.50%)
Apr 21, 2026, 1:52 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.14 billion as of April 20, 2026. Its market cap has decreased by -2.75% in one year.
Market Cap
1.14B
Enterprise Value
802.08M
Revenue
1.06B
Ranking
n/a
PE Ratio
8.20
Stock Price
92.24
Market Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.14B, an increase of 267.49%. That is a compound annual growth rate of 20.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.16B | -7.22% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 12.89B |
| Ind-Swift Laboratories | 11.43B |
| Sigachi Industries | 8.92B |
| Valiant Laboratories | 3.71B |
| Bafna Pharmaceuticals | 3.30B |
| Nectar Lifesciences | 2.46B |
| Brooks Laboratories | 1.99B |
| Alpa Laboratories | 1.45B |